Search
RESPOND Publications 2020

1 Uptake and discontinuation of integrase inhibitors (INSTIs) in a large cohort setting. Lauren Greenberg, Lene Ryom,  Gilles Wandeler, Katharina Grabmeier-Pfistershammer, Angela Öllinger, Bastian Neesgaard, Christoph Stephan, Alexandra Calmy, Andri Rauch, Antonella Castagna, Vincenzo Spagnuolo, Margaret Johnson, Christof Stingone, Cristina Mussini, Stéphane De Wit, Coca Necsoi, Antoni A Campins, Christian Pradier, Melanie Stecher, Jan-Christian Wasmuth, Antonella d’Arminio Monforte, Matthew Law, Rainer Puhr, Nikoloz Chkhartishvilli, Tengiz Tsertsvadze, Harmony Garges, David Thorpe, Jens D Lundgren, Lars Peters, Loveleen Bansi-Matharu, and Amanda Mocroft for the RESPOND study
J Acquir Immune Defic Syndr. 1;83(3):240-250. Abstract

2 Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral‐naïve persons starting treatment. Mocroft, A, and RESPOND study group.
HIV Med. 2020 Abstract

3 How to RESPOND to Modern Challenges for People Living with HIV: A Profile for a New Cohort Consortium. B Neesgaard *, A Mocroft, L Greenberg, JF Larsen, G Wandeler, R Zangerle, H Günthard, C Smith, S De Wit, C Mussini, A Castagna, a D'Arminio Monforte, JJ Vehreschild, JC Wasmuth, C Pradier, N Chkhartishvili, F W.N.M. Wit, M Law, A Sönnerborg, A Bruguera, C Stephan, V Vannappagari, R Haubrich, O Kirk, D Podlekareva, J Kowalska, D Raben, J Rockstroh, L Peters, R Parades, K Grabmeier-Pfistershammer, A Scherrer, M Johnson, C Necsoi, V Borghi, C Muccini, T Tserstvadze, K Petoumenos, A Volny-Anne, J Lundgren, L Ryom, for the RESPOND study group
Microorganisms. 2020;8(8):E1164. Abstract


IN PRESS